Scholarlink

<p>Feline calicivirus (FCV) is a highly infectious pathogen that causes upper respiratory tract disease (URTD), with a higher prevalence in group-housed cats compared to those raised individually. In this study, 15 FCV strains were isolated from group-housed cats exhibiting URTD symptoms in Changzhou, China, in 2024. Phylogenetic analysis based on the VP1 sequences revealed that 13 of 15 strains clustered within genogroup I (G I), while none belonged to genogroup II (G II). Notably, the remaining two strains grouped with several recently published Chinese isolates, forming an independent branch distinct from both G I and G II, proposed as genogroup III (G III). The VP1 proteins of the 13 G I strains exhibited specific residues 377N, 539A, and 557G, consistent with the established G I-specific markers (377N/S, 539A/P, and 557G). In contrast, G II strains typically retain 377&#xa0;K, 539&#xa0;V, and 557S. Interestingly, the G III strains displayed 377N, 539A (specific to G I) and 557S (specific to G II). Recombinant analysis found that co-circulating G I and G III resulted in a recombinant strain. Furthermore, neutralization tests demonstrated poor cross-neutralization between G I and G III strains. This study provides valuable insights for the development of effective vaccination strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Discovery of a novel genogroup feline calicivirus through molecular evolution in group-housed cats in China

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月30日

查看全文
  • Ya Zhang,
  • Zheng Cheng,
  • Cunjie Guo,
  • Tong Yang,
  • Wen Zhao,
  • Jing Qian,
  • Xingxia Xia,
  • Junming Bi,
  • Dawei Zhou,
  • Siyu Xu,
  • Zhimin Li,
  • Yumei Zhu,
  • Haitao Zhang,
  • Yeping Tan,
  • Zhenwei Bi

摘要

Feline calicivirus (FCV) is a highly infectious pathogen that causes upper respiratory tract disease (URTD), with a higher prevalence in group-housed cats compared to those raised individually. In this study, 15 FCV strains were isolated from group-housed cats exhibiting URTD symptoms in Changzhou, China, in 2024. Phylogenetic analysis based on the VP1 sequences revealed that 13 of 15 strains clustered within genogroup I (G I), while none belonged to genogroup II (G II). Notably, the remaining two strains grouped with several recently published Chinese isolates, forming an independent branch distinct from both G I and G II, proposed as genogroup III (G III). The VP1 proteins of the 13 G I strains exhibited specific residues 377N, 539A, and 557G, consistent with the established G I-specific markers (377N/S, 539A/P, and 557G). In contrast, G II strains typically retain 377 K, 539 V, and 557S. Interestingly, the G III strains displayed 377N, 539A (specific to G I) and 557S (specific to G II). Recombinant analysis found that co-circulating G I and G III resulted in a recombinant strain. Furthermore, neutralization tests demonstrated poor cross-neutralization between G I and G III strains. This study provides valuable insights for the development of effective vaccination strategies.